Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hims & Hers Health stock tanks
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's Q3 2024 revenue is expected to exceed projections as concerns rise over compounded GLP-1 medications.
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
Key Takeaways Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list of drugs in short supply. The FDA allows companies to produce compounded copycat drugs when the originals are hard to obtain,
Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list
Eli Lilly (LLY)'s weight loss drugs Mounjaro and Zepbound are no longer facing supply constraints, as the FDA has removed them from its shortage list — signaling the pharmaceutical giant's ability to now meet market demand.
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications. Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.
The FDA issued a warning about compounding pharmacies on weight-loss drugs
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies against skirting regulatory standards to put them on the market now that shortages are waning.
What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.
5h
on MSN
Mark Zuckerberg and Wife Priscilla Cause Stir With 'His and Hers' Cars
Zuckerberg and his wife, Priscilla Chan, have three young children, and he told fans on Instagram that she wanted a minivan ...
autoevolution
5h
Mark Zuckerberg Got His-and-Hers Porsches. Hers Is a One-Off Minivan He Designed
Though he was never the kind of show off on social media, Zuck couldn't help but share a look at his two new rides, including ...
3d
on MSN
For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.
4d
Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward
Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...
Vogue
16h
Jacob Elordi and Olivia Jade Do His-and-Hers Bottega Bags
Products are independently selected by our editors. We may earn an affiliate commission from links. Do you think Elordi and ...
4d
on MSN
Another Today Exit Was Allegedly Coming Before Hoda Announced Hers. Now NBC Is Apparently Hanging On Tightly
When you buy through links on our articles, Future and its syndication partners may earn a commission.
12d
Hims & Hers: The Gift That Keeps On Giving
Hims & Hers stock is currently in the middle of a deep drawdown. Read why I maintain my strong buy rating on HIMS stock.
Sampson Independent
4h
4-Hers earn prizes at Sampson Showcase
It was a beautiful day of friendly competition among 4-H youth last weekend as the young ag pupils faced off with their ...
What's on Netflix
4d
‘His & Hers’ Netflix Limited Series: Filming Underway & Everything We Know So Far
Filming is underway on Netflix's adaptation of Alice Feeney's His & Hers starring Tessa Thompson and Jon Bernthal.
3d
on MSN
These Stocks Moved the Most Today: EVgo, Levi Strauss, Humana, Hims & Hers, Nvidia, Tesla, Vistra, and More
Stocks were lower Thursday as traders weighed a greater-than-expected increase in weekly jobless claims and awaited the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Hims
Mark Zuckerberg
Eli Lilly
evgo stock
Homs
Feedback